New Medical Group Brings Personalized And Contemporary Cardiovascular Care To The Treasure Valley menafn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from menafn.com Daily Mail and Mail on Sunday newspapers.
Reducing sodium intake did not lead to a reduction in death/hospitalization in ambulatory patients with heart failure in the SODIUM-HF study, although symptoms appeared to improve.
E-Mail
Boston, MA (May 1, 2021) - Preliminary results of a clinical trial, presented today at the AATS 101st Annual Meeting, showed that a new, low-profile thoracic aortic endograft is safe and effective in the treatment of descending thoracic aortic aneurysm or penetrating atherosclerotic ulcer (PAU) diseases. A multi-disciplinary team, led by both cardiac and vascular surgeons as co-investigators, conducted the study in 36 centers in the United States and Japan, enrolling patients between 2016 and 2019.
The trial aimed to measure safety and efficacy of the RELAY®Pro endovascular device, a second-generation product featuring a dramatically reduced profile and a non-bare stent (NBS) configuration.